Capstone Investment Advisors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-162,100
Closed -$2.52M – 1665
2020
Q3
$2.52M Buy
+162,100
New +$2.79M 0.01% 732
2019
Q4
– Sell
-45,300
Closed -$990K – 1383
2019
Q3
$990K Sell
45,300
-71,500
-61% -$1.64M 0.01% 947
2019
Q2
$2.95M Buy
+116,800
New +$2.77M 0.02% 631
2018
Q1
– Sell
-10,000
Closed -$207K – 356
2017
Q4
$207K Buy
+10,000
New +$159K 0.01% 433
2016
Q2
– Sell
-20,000
Closed -$526K – 692
2016
Q1
$526K Buy
+20,000
New +$1.48M 0.02% 418
2014
Q2
– Sell
-45,300
Closed -$5.97M – 403
2014
Q1
$5.97M Buy
+45,300
New +$6.19M 0.08% 149

Other funds holding BHC

Capstone Investment Advisors's BHC Position: Q2 2026 in Review

Capstone Investment Advisors sold out of Bausch Health (BHC) in Q2 2026, closing a stake of 91,216 shares — an estimated $493K sold.

Capstone Investment Advisors first reported a position in BHC in Q1 2014 and held it in 19 quarters. The position peaked at $2.64M in Q1 2014. 221 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • Capstone Investment Advisors reported no remaining Bausch Health position as of Q2 2026 after selling out during the quarter.
  • Capstone Investment Advisors sold 91,216 Bausch Health shares in Q2 2026, an estimated $493K.
  • Capstone Investment Advisors first reported a position in Bausch Health in Q1 2014 and held it in 19 quarters.
  • Capstone Investment Advisors's Bausch Health position peaked at $2.64M in Q1 2014.
  • 221 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.